NOTE 19 — SUBSEQUENT EVENTS

In January 2026, a total of 3,926 shares of Series B Preferred Stock were converted into 1,747,781 shares of common stock at a conversion price of $2.246 per share. In February 2026, a total of 491 shares of Series B Preferred Stock were converted into 218,473 shares of common stock at a conversion price of $2.246 per share. In March 2026, a total of 29,441 shares of Series B Preferred Stock were converted into 13,108,357 shares of common stock at a conversion price of $2.246 per share.

In January 2026, the Company repaid $132,000 to Alpha Capital Anstalt in satisfaction of their outstanding convertible note.

In January 2026, the Company formed three new wholly owned subsidiaries, registered in Delaware, to structure our core digital asset an AI initiatives.

In January 2026, the Company entered into an entrusted investment agreement (the “Entrusted Investment Agreement”) with GOLD KING ARTHUR HOLDING LIMITED (“GKA”) and Song Wang (“Song”), pursuant to which the Company entrusted to GKA the management of an investment involving shares (“FFAI Shares”) of Class A common stock, par value $0.0001 per share (“FFAI Class A Common Stock”), of Faraday Future Intelligent Electric Inc. (“Faraday”). In connection with the Entrusted Investment Agreement, on the same date, GKA and Faraday entered into a securities purchase agreement (the “GKA SPA”) providing for the potential purchase of FFAI Shares for an aggregate consideration of $10,000,000. The number of Faraday Shares to be issued under the GKA SPA will be determined based on the closing price of FFAI Class A Common Stock on the trading day immediately prior to the closing date, and the closing is subject to customary conditions. As these agreements were executed after the balance sheet date and do not provide evidence of conditions existing as of that date, they represent non-recognized subsequent events under ASC 855, and no adjustments have been made to the Company’s consolidated financial statements.

On March 20, 2026, FFAI filed a Current Report on Form 8-K disclosing receipt of a deficiency notice from Nasdaq for failing to maintain the minimum $1.00 bid price required by Nasdaq Listing Rule 5550(a)(2). Given the recent $10.0 million investment in FFAI disclosed above, a potential delisting introduces significant liquidity and valuation risks to our holding if FFAI fails to regain compliance during its allotted cure period. Additional details regarding the deficiency notice and FFAI’s compliance plans can be found in the Form 8-K filed by FFAI.